7x Winner of the MMIT Patient Choice Award!

Give us a call 855.726.8479 | 412.246.9858

Patient Portal Login

BYLVAY® (odevixibat)
https://bylvay.com/

BYLVAY® (odevixibat) is indicated for the treatment of pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC) or for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS)

Resources

About PFIC (bylvay.com) EXPLORE

PFIC Advocacy & Resource Network, Inc. EXPLORE

Resources

The Childhood Disease Research Network (ALGS): Alagille Syndrome (childrennetwork.org) EXPLORE

Rare Disease Advisor (ALGS): Alagille Syndrome Diagnosis - Rare Disease Advisor EXPLORE

NORD (ALGS): Alagille Syndrome - Symptoms, Causes, Treatment | NORD (rarediseases.org) EXPLORE

PANTHERx Rare Contact

877-628-6960

Manufacturer Contact

Albireo Pharma, Inc., an Ipsen Company
https://bylvay.com/
800-252-4736

24 Summit Park Drive
Pittsburgh, PA 15275 USA

Phone: 855.726.8479
(412.246.9858)

Fax: 855.246.3986
(412.787.9400)

Email: pharmacist@pantherxrare.com

Who We Serve
Patients
Manufacturers
Prescribers
Payers

About Us
Company Overview
Our History
Our Leadership
Press Releases

Resources
Patients
Prescribers
Medications
Careers
Contact Us

Connect

Copyright © 2024 PANTHERx Rare, LLC. All rights reserved. PANTHERx RARE PHARMACY, “REINVENTING PHARMACY, REVOLUTIONIZING SPECIALTY, REDEFINING CARE”, and THE RARE DISEASE SP are registered service marks of PANTHERx Rare, LLC.

Twilio SMS Terms & Conditions | Privacy Policy | Legal Disclosure